Nā SyncoZymes

nūhou

Nūhou maikaʻi: Ua ʻike ʻia ʻo Syncozymes ma ke ʻano he papahana hoʻololi hoʻokō ʻenehana kiʻekiʻe

Ma Ianuali 5, 2021, ua hāʻawi ʻia ʻo Shangke Biopharmaceutical (Shanghai) Co., Ltd. i ka Papahana Hoʻololi Hoʻokō ʻenehana Kiʻekiʻe o Shanghai "(S)-1-tert-butoxycarbonyl-3-hydroxypiperidine".

Ma ke ʻano he ʻoihana ʻenehana kiʻekiʻe aupuni, lawe mau ʻo Suntech Biotech i ka biotechnology e alakaʻi i ka hoʻomohala ʻana o ka ʻoihana kemika a me ka lāʻau lapaʻau, a lawe mai i ka ʻōmaʻomaʻo a me ke olakino i nā kānaka ma ke ʻano he misionari. No ka hoʻonui ʻana i ka ʻoihana ma nā ʻano he nui, e hana pū me nā kula a me nā ʻoihana kaulana ma ka home a ma waho, e hoʻomohala mau i kona hiki ke hoʻomohala ponoʻī, e hoʻomaikaʻi i ka hoʻonohonoho kūloko o ka ʻoihana, a e lilo i ʻoi aku ka maikaʻi a me ka ikaika.

ka hoʻokō ʻenehana kiʻekiʻe

Inoa papahana: (S)-1-tert-Butoxycarbonyl-3-hydroxypiperidine
Helu Mea: 202010694
Pae mea: B
Inā he mau hoʻokō i ke kahua ʻenehana kiʻekiʻe me nā kuleana waiwai kūʻokoʻa: ʻAe

Hoʻohana: ʻO (S)-1-tert-butoxycarbonyl-3-hydroxypiperidine (CAS: 143900-44-1) kahi waena chiral koʻikoʻi no ka synthesis o nā ibrutinib APIs. ʻO Ibrutinib kahi lāʻau anticancer hou e kuhikuhi ana i nā maʻi ʻino B-cell i ʻae ʻia ma lalo o ka ʻae wikiwiki ʻia e ka US Food and Drug Administration (FDA) ma Nowemapa 13, 2013 no ka mālama ʻana i ka lymphoma.

Ka wehewehe ʻana o ka hoʻololi ʻana i ka hoʻokō ʻenehana kiʻekiʻe
ʻO ka hoʻololi ʻana o nā hoʻokō ʻenehana kiʻekiʻe e pili ana i ke kaʻina hana e hana ai nā ʻoihana i ka hana a me ka hana ʻenehana kiʻekiʻe. Kākoʻo ke aupuni i nā ʻoihana e hoʻokō i ka hoʻololi ʻana o nā hoʻokō ʻepekema a me ka ʻenehana ma o ka noiʻi kūʻokoʻa a me ka hoʻomohala ʻana, ka hāʻawi ʻana i nā laikini, ka lawe ʻana i nā ʻāpana ma ke kumukūʻai, a me ka hana pū ʻana me nā ʻoihana, nā kulanui a me nā ʻoihana noiʻi. No nā papahana hoʻololi hoʻokō ʻenehana kiʻekiʻe i loiloi ʻia a hōʻike ʻia e ka ʻoihana, e like me ka hoʻopau ʻana o kāna mau hōʻailona waiwai piha a me nā ʻano o nā kuleana waiwai noʻeau o ka papahana, ke kiʻekiʻe o ka hana hou, a me nā mea ʻē aʻe, pili kāna hoʻopukapuka R&D i nā kuleana waiwai noʻeau e pili ana i ka papahana, nā palapala hōʻoia patent mea hou, a i ʻole nā ​​mea e komo ana i ke kahua hoʻokolokolo koʻikoʻi. Hoʻopuka ʻia ka palapala hōʻoia hanohano i ka ʻoihana ma hope o ka loiloi koʻikoʻi a me ka noiʻi piha ʻana i ka mākeke, e like me nā mea hōʻoia o ka noi patent mea hou, palapala hōʻoia patent kumu hoʻohālike pono, palapala hōʻoia hoʻopaʻa inoa kope kope polokalamu, palapala hōʻoia hoʻopaʻa inoa hoʻolālā hoʻonohonoho kaapuni hoʻohui, a me nā mea ʻē aʻe.

ʻIkepili Hui
Ua hoʻokumu ʻia ʻo Shangke Biomedical (Shanghai) Co., Ltd. i ka makahiki 2008 a aia ma ka International Medical Park, ma ka ʻaoʻao hema o Zhangjiang Hi-Tech Park, Pudong, Shanghai. He lālā piha ia no Zhejiang Shangke Biomedical Co., Ltd. Ua kūpaʻa ʻo Shangke Bio i ka noiʻi a me ka hoʻomohala ʻana i ke kahua lāʻau lapaʻau ʻōmaʻomaʻo ʻoi loa, alakaʻi i ka hoʻomohala ʻana o ka ʻoihana lāʻau lapaʻau kemika me ka biotechnology ʻōmaʻomaʻo, a hāʻawi i nā huahana hou a me nā lawelawe kiʻekiʻe no ka ʻoihana lāʻau lapaʻau. He ʻoihana ʻenehana kiʻekiʻe ma Shanghai a he ʻoihana ʻenehana kiʻekiʻe ʻo Shanghai "ʻoihana kūikawā, hoʻomaʻemaʻe, kūikawā a hou".

ʻO ka ʻoihana nui a Suntech: ka hoʻomohala ʻana a me ka hoʻohana ʻana i nā enzymes biological, ka hoʻomohala ʻana a me ka hana ʻana i nā mea waena lāʻau lapaʻau, nā API a me nā kemika hana. ʻO nā huahana nui a ka hui he mau huahana coenzyme, me NMN, NAD, NADP, NADH, NADPH, nā enzymes biological, nā mea maka lāʻau lapaʻau a me nā mea waena. Aia nā mea kūʻai aku a me nā hoa o ka hui ma ka honua holoʻokoʻa, a ua hoʻokumu i nā pilina pili me nā ʻoihana lāʻau lapaʻau he nui ma ʻAmelika ʻĀkau, ʻEulopa, India a me Kina.


Ka manawa hoʻouna: Ian-15-2021